Castilla-Cortazar (2016) Insulin-like growth factor-1 deficiency and metabolic syndrome Journal of Translational Medicine volume 14, Article number: 3 (2016)
Semaglutide GLP-1s ability to reduce hunger and curb food cravings by acting on specific brain areas involved in appetite regulation aligns with our holistic approach
Be mindful of potential environmental toxins, which can contribute to liver disease
Their use was guided by diabetes-specific protocols, specialist oversight, and structured escalation pathways tied to glycemic targets
Mild nausea, reduced appetite, and digestive changes may occur initially, but usually settle with gradual dose adjustment and medical supervision
Participants were adults aged 18 or older with a BMI of 30 kg/m or 27 kg/m with at least one weight-related comorbidity